Stock listing
LS Exchange:A2AC4K Editas Medicine, Inc. Aktie
German listing (LS Exchange) of Editas Medicine, Inc. · home listing NASDAQ:EDIT
Follow Editas Medicine, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:EDIT
$2.58 USD +0.16 (+6.6%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:EDIT
- Day range
- $2.35 – $2.67 USDOct 20, 2026
- Volume
- 2.25M sharesOct 20, 2026
- Market cap
- $396.2M USDAt the close on Oct 20, 2026 · price × 153.6M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:EDIT · Home | $2.58 USD | +0.16 (+6.6%) | 2,245,766 | $2.40 | $2.665 | $2.35 | $2.42 | Close on Oct 20, 2026 |
| LSE:0IFK | $2.651 USD | +0.341 (+14.8%) | 12,059 | $2.396 | $2.651 | $2.38 | $2.31 | Close on Oct 20, 2026 |
| Frankfurt:8EM | €2.11 EUR | +0.03 (+1.4%) | — | €2.11 | €2.11 | €2.11 | €2.08 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:EDIT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.58 | +0.16 | +6.6% | $2.40 | $2.665 | $2.35 | 2,245,766 | |
| $2.42 | +0.07 | +3.0% | $2.39 | $2.43 | $2.27 | 2,009,894 | |
| $2.35 | -0.09 | -3.7% | $2.44 | $2.47 | $2.33 | 1,551,219 | |
| $2.44 | +0.17 | +7.5% | $2.26 | $2.465 | $2.25 | 1,858,481 | |
| $2.27 | -0.175 | -7.2% | $2.44 | $2.475 | $2.245 | 2,821,875 | |
| $2.445 | -0.305 | -11.1% | $2.73 | $2.73 | $2.44 | 2,447,978 | |
| $2.75 | -0.15 | -5.2% | $2.90 | $2.91 | $2.73 | 1,295,836 | |
| $2.90 | +0.06 | +2.1% | $2.85 | $2.97 | $2.71 | 3,087,544 | |
| $2.84 | +0.09 | +3.3% | $2.79 | $2.945 | $2.69 | 6,067,650 | |
| $2.75 | +0.02 | +0.7% | $2.71 | $2.845 | $2.659 | 2,264,997 | |
| $2.73 | -0.06 | -2.2% | $2.85 | $2.895 | $2.715 | 2,967,500 | |
| $2.79 | +0.17 | +6.5% | $2.62 | $2.81 | $2.555 | 3,012,000 | |
| $2.62 | +0.10 | +4.0% | $2.57 | $2.63 | $2.51 | 2,162,800 | |
| $2.52 | -0.05 | -1.9% | $2.61 | $2.62 | $2.52 | 1,544,200 | |
| $2.57 | -0.02 | -0.8% | $2.61 | $2.72 | $2.55 | 1,624,500 | |
| $2.59 | +0.08 | +3.2% | $2.54 | $2.62 | $2.51 | 1,568,500 | |
| $2.51 | -0.07 | -2.7% | $2.55 | $2.55 | $2.42 | 2,203,200 | |
| $2.58 | -0.17 | -6.2% | $2.76 | $2.78 | $2.57 | 3,117,600 | |
| $2.75 | +0.06 | +2.2% | $2.66 | $2.76 | $2.545 | 2,589,800 | |
| $2.69 | -0.23 | -7.9% | $3.12 | $3.14 | $2.67 | 5,161,700 | |
| $2.92 | +0.09 | +3.2% | $2.86 | $2.93 | $2.805 | 2,293,900 | |
| $2.83 | +0.13 | +4.8% | $2.76 | $2.89 | $2.695 | 2,489,000 | |
| $2.70 | -0.02 | -0.7% | $2.73 | $2.825 | $2.68 | 17,028,800 | |
| $2.72 | +0.01 | +0.4% | $2.80 | $2.945 | $2.71 | 3,512,900 | |
| $2.71 | +0.08 | +3.0% | $2.65 | $2.73 | $2.63 | 2,493,500 | |
| $2.63 | -0.11 | -4.0% | $2.70 | $2.71 | $2.59 | 1,680,500 | |
| $2.74 | +0.04 | +1.5% | $2.72 | $2.815 | $2.66 | 1,687,100 | |
| $2.70 | +0.05 | +1.9% | $2.68 | $2.72 | $2.62 | 2,463,600 | |
| $2.65 | -0.12 | -4.3% | $2.77 | $2.77 | $2.62 | 2,543,400 | |
| $2.77 | -0.26 | -8.6% | $3.06 | $3.06 | $2.77 | 2,963,000 | |
| $3.03 | -0.20 | -6.2% | $3.20 | $3.215 | $3.01 | 2,275,700 | |
| $3.23 | +0.15 | +4.9% | $3.04 | $3.23 | $3.04 | 1,390,400 | |
| $3.08 | 0.00 | 0.0% | $3.09 | $3.13 | $3.00 | 1,378,100 | |
| $3.08 | +0.01 | +0.3% | $3.09 | $3.23 | $2.98 | 1,678,500 | |
| $3.07 | +0.01 | +0.3% | $3.00 | $3.155 | $2.98 | 1,225,200 | |
| $3.06 | -0.10 | -3.2% | $3.12 | $3.14 | $3.025 | 2,075,700 | |
| $3.16 | -0.14 | -4.2% | $3.25 | $3.41 | $3.15 | 3,270,100 | |
| $3.30 | +0.12 | +3.8% | $3.17 | $3.37 | $3.15 | 2,665,000 | |
| $3.18 | -0.10 | -3.0% | $3.40 | $3.515 | $3.16 | 2,944,000 | |
| $3.28 | +0.28 | +9.3% | $3.05 | $3.33 | $3.05 | 4,212,991 | |
| $3.00 | -0.11 | -3.5% | $3.14 | $3.18 | $2.97 | 2,062,340 | |
| $3.11 | +0.17 | +5.8% | $2.98 | $3.245 | $2.95 | 2,109,000 | |
| $2.94 | -0.31 | -9.5% | $3.17 | $3.229 | $2.92 | 4,262,300 | |
| $3.25 | +0.37 | +12.8% | $3.01 | $3.30 | $2.99 | 9,641,300 | |
| $2.88 | +0.04 | +1.4% | $2.89 | $2.99 | $2.80 | 2,232,600 | |
| $2.84 | +0.02 | +0.7% | $2.80 | $2.895 | $2.77 | 2,113,700 | |
| $2.82 | +0.01 | +0.4% | $2.81 | $2.845 | $2.715 | 1,478,000 | |
| $2.81 | -0.03 | -1.1% | $2.85 | $2.90 | $2.81 | 1,272,400 | |
| $2.84 | -0.11 | -3.7% | $2.96 | $3.025 | $2.82 | 1,629,900 | |
| $2.95 | +0.14 | +5.0% | $2.84 | $2.99 | $2.83 | 1,910,800 | |
| $2.81 | -0.07 | -2.4% | $2.84 | $2.90 | $2.79 | 1,464,800 | |
| $2.88 | -0.02 | -0.7% | $2.99 | $3.09 | $2.87 | 1,692,900 | |
| $2.90 | +0.15 | +5.5% | $2.82 | $3.14 | $2.81 | 3,429,400 | |
| $2.75 | -0.02 | -0.7% | $2.79 | $2.87 | $2.745 | 1,938,300 | |
| $2.77 | +0.12 | +4.5% | $2.69 | $2.78 | $2.64 | 1,559,400 | |
| $2.65 | +0.07 | +2.7% | $2.60 | $2.65 | $2.53 | 775,100 | |
| $2.58 | -0.11 | -4.1% | $2.67 | $2.703 | $2.53 | 1,180,800 | |
| $2.69 | +0.09 | +3.5% | $2.60 | $2.705 | $2.60 | 834,000 | |
| $2.60 | -0.02 | -0.8% | $2.59 | $2.66 | $2.53 | 1,528,500 | |
| $2.62 | -0.06 | -2.2% | $2.67 | $2.675 | $2.52 | 1,464,100 | |
| $2.68 | +0.08 | +3.1% | $2.63 | $2.725 | $2.603 | 937,200 | |
| $2.60 | -0.13 | -4.8% | $2.75 | $2.755 | $2.59 | 1,516,700 | |
| $2.73 | -0.05 | -1.8% | $2.71 | $2.77 | $2.69 | 1,437,000 | |
| $2.78 | -0.11 | -3.8% | $2.85 | $2.885 | $2.73 | 1,038,300 | |
| $2.89 | +0.01 | +0.3% | $2.86 | $2.955 | $2.855 | 1,146,200 | |
| $2.88 | -0.10 | -3.4% | $2.96 | $3.07 | $2.85 | 1,402,400 |
- Ticker
- LS Exchange:A2AC4K
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LS Exchange
- Currency
- EUR
What changed lately
Latest news release · Oct 14, 2026
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Latest deck · June 2026
Investor Presentation (June 2026)
Investor deck · 17 slides
Calls
Replays
Editas Medicine (NASDAQ:EDIT) Q2 2024 Earnings Call
Wed, Aug 07, 2024 · 8:00 AM ET
Watch TranscriptEditas Medicine (NASDAQ:EDIT) Q1 2024 Earnings Call
Wed, May 08, 2024 · 8:00 AM ET
Watch TranscriptEditas Medicine (NASDAQ:EDIT) Q4 2023 Earnings Call
Wed, Feb 28, 2024 · 8:00 AM ET
Watch Transcript
Latest news
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Oct 14, 2026
Closed $2.27 (-7.2%) on Oct 14, 2026
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
Oct 8, 2026
Closed $2.84 (+3.3%) on Oct 8, 2026
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Sep 8, 2026
Closed $3.03 (-6.2%) on Sep 8, 2026
Editas Medicine Announces Second Quarter 2026 Results and Business Updates
Aug 5, 2026
Closed $2.90 (+5.5%) on Aug 6, 2026
Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D., Ph.D.
Aug 4, 2026
Closed $2.75 (-0.7%) on Aug 5, 2026
Decks
Investor Presentation (June 2026)
Investor deck · 17 slides · June 2026
TIDES 2026
Conference · 20 slides · May 14, 2026
ASGCT 29th Annual Meeting 2026
Conference · 20 slides · May 2026
ASGCT 28th Annual Meeting 2025
Conference · 8 slides · May 2025
Editas Medicine, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 187 in all · newest Oct 14, 2026 · oldest 2019
- Calls
- 16 calls with a replay · 16 with a transcript · latest Aug 7, 2024
- Decks
- 25 decks · latest June 2026
Where Editas Medicine, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EDIT · Home listing | NASDAQ | United States | USD |
| gettex:8EM | gettex | Germany | EUR |
| BOATS:EDIT | BOATS | United States | USD |
| Tradegate:8EM | Tradegate | Germany | EUR |
| LS Exchange:A2AC4K · This page | LS Exchange | Germany | EUR |
| Stuttgart:8EM | Stuttgart | Germany | EUR |
| Lang & Schwarz:A2AC4K | Lang & Schwarz | Germany | EUR |
| LSE:0IFK | LSE | United Kingdom | USD |
| Frankfurt:8EM | Frankfurt | Germany | EUR |
| BX Swiss:8EM | BX Swiss | Switzerland | CHF |
| Dusseldorf:8EM | Dusseldorf | Germany | EUR |
| Hamburg:8EM | Hamburg | Germany | EUR |
| Munich:8EM | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Editas Medicine, Inc.